Black Rose Industries Ltd Q4 FY26 results (latest), Jan–Mar 2026 →Revenue ₹104 Cr +25.5% YoYSee revenue, profit and what management said. You are viewing Q3 FY20.
BR

Black Rose Industries Ltd

Q3 FY20Chemicals & Petrochemicals

Black Rose Industries Q3 FY20 earnings call: Revenue & Margins

Q3 FY20 investor presentation: what the company reported on revenue, margins and capex.

Black Rose Industries Ltd Q3 FY20 key numbers

Revenue
Revenue (Income from operations) for 9 months FY20: Rs. 1,862.3 million; 16% growth year-on-year.

As stated in Black Rose Industries Ltd's Q3 FY20 investor presentation · published 24 Sept 2026. Reported figures, not investment advice.

Based on Black Rose Industries Ltd's Q3 FY20 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹113
Market cap₹543 Cr
P/E18.9

The short version

Revenue (Income from operations) for 9 months FY20: Rs. 1,862.3 million; 16% growth year-on-year. EBITDA for 9M FY20: Rs. 245.5 million.

From Black Rose Industries Ltd's Q3 FY20 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Revenue (Income from operations) for 9 months FY20: Rs. 1,862.3 million; 16% growth year-on-year.
  • Distribution sales for 9M FY20: Rs. 1,290 million; 26% annualized sales growth compared to previous years.
  • Acrylamide manufacturing: Crossed 90% capacity utilization in October 2019; current capacity 20,000 MTPA for merchant sales plus captive intermediate use.

2 more points from Black Rose Industries Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Black Rose Industries Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Acrylamide plant: Initial capex Rs. 369 mn; additional capacity expansion capex Rs. 32.5 mn funded from internal accruals; capacity 20,000 MTPA for merchant sales plus captive use; further expansion possible at existing site (Page 15).
  • Polyacrylamide liquids plant: Capacity 40,000 MTPA (under commissioning); timelines include October 2019 - 120 MTPA, January 2020 - 6,600 MTPA (Page 20).
  • Capacity expansions are phased with focus on maximizing utilization and marginal capex for incremental additions (Page 16).

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Black Rose Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Key points related to orders include: - It highlights capacity expansions (e.g., polyacrylamide solids: 10,000 MTPA in progress; liquids: 40,000 MTPA under commissioning). - Sales growth figures are provided for distribution business, e.g., Rs. 908 mn in 2015-16 to Rs. 1,290 mn (annualized) in 9M FY20.

Black Rose Industries Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹104 Cr, net profit ₹9 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Black Rose Industries Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Black Rose Industries Ltd Q3 FY20 results?

Revenue (Income from operations) for 9 months FY20: Rs. 1,862.3 million; 16% growth year-on-year. EBITDA for 9M FY20: Rs. 245.5 million.

What is Black Rose Industries Ltd share price analysis?

Black Rose Industries Ltd currently shows a neutral. The stock trades at a P/E of 18.9 with a market cap of ₹543 Cr. Investors should review the full earnings analysis for detailed insights.

Is Black Rose Industries Ltd planning capital expenditure?

Acrylamide plant: Initial capex Rs. 369 mn; additional capacity expansion capex Rs. 32.5 mn funded from internal accruals; capacity 20,000 MTPA for merchant sales plus captive use; further expansion p.

Keep Black Rose Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.